NL-OMON26543招募中不适用
Tacrolimus monotherapy in immunologically low-risk kidney transplant recipients: a pilot randomized-controlled study.
Erasmus Medical Center, Rotterdam, The Netherlands0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adult patients receiving a deceased or living kidney transplant in the Erasmus Medical Center Rotterdam, The Netherlands and:
- •-Historical PRA <5% and
排除标准
- •-HLA identical living-related transplant recipients.
- •-Patients with an indication to continue MMF or other immunosuppressive drugs, e.g. vasculitis, SLE etc. (according to judgement of treating physician).
研究者
相似试验
尚未招募
2 期
In patients with the cancer called Hodgkins lymphoma we are trying to see whether adding a medicine stimulating the immune system will increase the benefit of usual treatmentCTRI/2023/11/060108Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
已完成
1 期
A combination immunotherapy for the patients with advanced or metastatic solid cancersolid cancerJPRN-UMIN000020440Yamaguchi university Graduate School of Medicine17
进行中（未招募）
1 期
Phase II Study of efti plus pembrolizumab combination therapy for head and neck cancer (HNSCC)Metastatic head and neck squamous cell carcinoma (HNSCC)MedDRA version: 27.0Level: PTClassification code 10071540Term: Head and neck cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-000055-39-DKImmutep S.A.S.154
进行中（未招募）
1 期
Phase II Study of efti plus pembrolizumab combination therapy for head and neck cancer (HNSCC)Metastatic head and neck squamous cell carcinoma (HNSCC)MedDRA version: 21.1Level: PTClassification code 10071540Term: Head and neck cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-000055-39-BEImmutep S.A.S.154
进行中（未招募）
1 期
Phase II Study of efti plus pembrolizumab combination therapy for head and neck cancer (HNSCC)Metastatic head and neck squamous cell carcinoma (HNSCC)MedDRA version: 21.1Level: PTClassification code 10071540Term: Head and neck cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-000055-39-ESImmutep S.A.S.154